Byron Robinson

Insider Reports History

Entity
Individual
Location
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Byron Robinson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Strategy Officer Common Stock 28K $1.61M $57.37 Jan 2, 2025 Direct
Janux Therapeutics, Inc. Chief Strategy Officer Stock option (right to buy) 98K Jan 2, 2025 Direct

Insider Reports Filed by Byron Robinson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jan 2, 2025 2 $0 4 Jan 3, 2025 Chief Strategy Officer
JANX Janux Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 3, 2024 Chief Strategy Officer
JANX Janux Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Strategy Officer
JANX Janux Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Chief Strategy Officer
JANX Janux Therapeutics, Inc. Mar 1, 2022 0 $0 3 Mar 3, 2022 Chief Strategy Officer